Year: 2026
Type: review
Abstract: Pediatric brain tumors are the leading cause of disease-related death in children, yet effective treatment remains a major clinical challenge. These aggressive tumors have limited therapeutic options capable of crossing the blood-brain barrier (BBB) and frequently recur due to genetic or epigenetic alterations and treatment resistance. Gene therapy offers a promising strategy to address these limitations by modifying gene expression, correcting mutations, or introducing functional genes. Nanoparticle (NP) delivery systems facilitate this approach by protecting genetic cargo and enabling BBB penetration and tumor-specific uptake. This review summarizes current genetic engineering strategies and NP-based delivery systems for pediatric brain tumors, including their design principles and delivery mechanisms, highlights key therapeutic approaches under preclinical and clinical investigations, and discusses the major challenges and future directions in NP-mediated gene therapy for pediatric neuro-oncology. By critically evaluating these developments, we aim to underscore the transformative potential of NP-mediated gene therapies in reshaping treatment paradigms and improving outcomes and quality of life for children.
Source: Science Advances
Authors: Jiayuan Zhu(Conceptualization, Formal analysis, Investigation, Visualization, Writing – original draft, Writing – review & editing), Helen Forgham(Conceptualization, Data curation, Methodology, Writing – original draft, Writing – review & editing), Yu Qin(Conceptualization, Writing – original draft), Xiaodi Li(Writing – original draft, Writing – review & editing), Xueguang Lu(Writing – review & editing), Sui Wang(Writing – review & editing), David S. Ziegler(Funding acquisition, Supervision, Writing – review & editing), Maria Kavallaris(Conceptualization, Funding acquisition, Writing – review & editing), Thomas P. Davis(Conceptualization, Funding acquisition, Investigation, Methodology, Project administration, Resources, Supervision, Writing – review & editing), Ruirui Qiao(Conceptualization, Funding acquisition, Project administration, Supervision, Visualization, Writing – review & editing)
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $4,500
Awards: Childhood cancer precision diagnostics and therapeutics , Novel approaches to Nanomedicines for future therapies, Advancing the treatment of brain cancer in children, G8056820439, Bio-inspired Nanoparticles for Mechano-Regulation of Stem Cell Fate, Biocompatible Gadolinium-free contrast agents for molecular targeted MR imaging
OpenAlex ID: W7236155176
